Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial

NCT03942354 · clinicaltrials.gov ↗

COMPLETED

Status

137

Enrollment

OTHER

Sponsor class

Conditions

Multidrug Resistant Tuberculosis

Interventions

DRUG: Bedaquiline
DRUG: Pretomanid
DRUG: Moxifloxacin
DRUG: Linezolid
DRUG: Clofazimine
DRUG: Directly observed therapy (DOT)

Sponsor

Medecins Sans Frontieres, Netherlands

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]